CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 


Atara Biotherapeutics Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



ATRA Net Cash Flow Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 23.21 % -93 % -41.84 % -97.07 % -16.96 %
Seq. Revenue Change 52.23 % -15.16 % 1824.89 % -95.04 % -91.36 %
Revenue In Millions $5.49 $3.61 $4.25 $0.22 $4.46
Net Cash Flow Margin - -78.78 % -1039.05 % - -125.01 %
Net Cash Flow Margin Total Ranking # 152 # # # 33 # 1
Net Cash Flow In Millions $18.89 $-2.84 $-44.20 $26.63 $-5.57
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2023 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 343.88 %, a new company low.

Observing third quarter 2023 results within Biotechnology & Pharmaceuticals industry 18 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 152.

ATRA's Net Cash Flow Margin third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 19
Healthcare Sector # 69
Overall # 153

Net Cash Flow Margin Statistics
High Average Low
12048.87 % 6196.38 % 343.88 %
(Dec 31 2022)   (Sep 30 2023)




Other Net Cash Flow Margin Profitability Ratios
ATRA's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
ATRA's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for ATRA's Competitors
Net Cash Flow Margin Profit Margin for Atara Biotherapeutics Inc 's Suppliers
Net Cash Flow Margin Profit Margin for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Net Cash Flow Growth
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginSep 30 2023 MRQ Net Cash FlowSep 30 2023 MRQ Revenue
Gamida Cell Ltd   923.92 %$ 6.218 $ 0.673 
Kymera Therapeutics Inc   606.13 %$ 28.658 $ 4.728 
Titan Pharmaceuticals Inc   460.08 %$ 7.987 $ 1.736 
Dyadic International Inc  393.29 %$ 1.562 $ 0.397 
Atara Biotherapeutics Inc   343.88 %$ 18.893 $ 5.494 
4d Molecular Therapeutics Inc   194.85 %$ 39.367 $ 20.204 
Cyclo Therapeutics Inc   193.81 %$ 0.960 $ 0.495 
Curis Inc   160.78 %$ 4.555 $ 2.833 
Caribou Biosciences Inc   160.02 %$ 37.864 $ 23.662 
C4 Therapeutics Inc   146.90 %$ 16.265 $ 11.072 
Eiger Biopharmaceuticals Inc   140.79 %$ 4.518 $ 3.209 
Adaptimmune Therapeutics Plc  135.95 %$ 12.872 $ 9.468 
Elutia inc   89.39 %$ 5.221 $ 5.841 
Novavax inc  79.38 %$ 148.422 $ 186.986 
Organicell Regenerative Medicine Inc  78.95 %$ 1.123 $ 1.422 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com